2022年ERC-ESICM成人心脏骤停后温度控制临床实践指南解读

师维, 陆宗庆, 崔旋旋, 等. 2022年ERC-ESICM成人心脏骤停后温度控制临床实践指南解读[J]. 临床急诊杂志, 2022, 23(6): 371-377. doi: 10.13201/j.issn.1009-5918.2022.06.001
引用本文: 师维, 陆宗庆, 崔旋旋, 等. 2022年ERC-ESICM成人心脏骤停后温度控制临床实践指南解读[J]. 临床急诊杂志, 2022, 23(6): 371-377. doi: 10.13201/j.issn.1009-5918.2022.06.001
SHI Wei, LU Zongqing, CUI Xuanxuan, et al. Interpretation of the 2022 ERC-ESICM clinical practice guidelines for temperature control in adults after cardiac arrest[J]. J Clin Emerg, 2022, 23(6): 371-377. doi: 10.13201/j.issn.1009-5918.2022.06.001
Citation: SHI Wei, LU Zongqing, CUI Xuanxuan, et al. Interpretation of the 2022 ERC-ESICM clinical practice guidelines for temperature control in adults after cardiac arrest[J]. J Clin Emerg, 2022, 23(6): 371-377. doi: 10.13201/j.issn.1009-5918.2022.06.001

2022年ERC-ESICM成人心脏骤停后温度控制临床实践指南解读

  • 基金项目:
    国家自然科学基金(No:82072134);国家自然科学基金青年基金(No:81601661)
详细信息

Interpretation of the 2022 ERC-ESICM clinical practice guidelines for temperature control in adults after cardiac arrest

More Information
  • 基于随机对照试验、系统评价和荟萃分析,心脏骤停复苏后患者使用目标温度管理(TTM)进行温度控制已得到专家协会的认可和国际临床实践指南的推荐。近期TTM-2试验报告指出具有任何初始心律的1850例院外心脏骤停(OHCA)昏迷患者温度控制在33℃与仅在患者发热(>37.7℃)时进行干预,6个月的病死率或神经功能结局没有差异,故欧洲复苏委员会(ERC)和欧洲危重病医学会(ESICM)更新了温度控制的临床实践指南,为具有任何初始节律的院内或院外心脏骤停复苏后昏迷的成人患者提供基于循证的体温控制指导。本文对其重点内容进行解读,为国内临床医师更好的学习和了解最新进展。
  • 加载中
  • 表 1  ILCOR系统评价的PICO原则

    研究对象 干预措施 对照设计 结局指标
    院内或院外心脏骤停的成人患者 目标体温为32~34℃时的温度控制 对体温正常或预防发热的温度控制 任何临床结果
    特定的TTM持续时间(如48 h) 不同的TTM持续时间(如24 h)
    特定的TTM降温方法(如体表降温) 不同的TTM降温方法(如血管内降温)
    特定目标温度下的TTM(如33℃) 不同目标温度下的TTM(如36℃)
    在特定时间点之前前诱导TTM(如院前或心脏骤停期间,即恢复自主循环之前) 在特定时间点之后诱导TTM
    具有特定复温速率的TTM 具有不同的复温速率或无复温速率的TTM
    注:PICO临床结果包括但不一定限于ROSC、入院28 d、入院30 d、出院时的生存率或良好神经功能结局,以及出院后28 d、30 d、90 d、180 d、1年的生存率或良好神经功能结局。ILCOR的ALS工作组以生存率和长期神经功能结局为重点进行了先验排序。
    下载: 导出CSV

    表 2  ERC-ESICM对成人心脏骤停后温度控制的建议

    推荐强度及质量等级 建议
    最佳实践声明 对于心脏骤停ROSC后处于昏迷状态的患者,推荐持续监测核心温度
    弱推荐,低质量证据 对于心脏骤停后处于昏迷状态的患者,推荐积极预防发热(>37^7℃)
    最佳实践声明 对于心脏骤停后处于昏迷状态的患者,推荐积极预防发热至少72 h
    最佳实践声明 温度控制可以通过让患者暴露在环境中,使用解热药物,如果无法达标,可以使用目标温度为37^5℃的冷却装置
    最佳实践声明 目前没有足够的证据支持或反对在心脏骤停患者亚群中控制32~36℃的温度或进行早期降温,未来的研究可能有助于阐明这一点。不推荐对ROSC后处于轻度低温状态的昏迷患者进行复温以达到常温
    强反对,中等质量证据 不推荐ROSC后立即快速输注大量冷静脉液体进行院前降温
    下载: 导出CSV

    表 3  未来心脏骤停后温度控制研究关注的问题

    序号 关注研究的问题
    1 尚未有正常体温/预防发热与无体温控制进行比较的试验
    2 关于IHCA后温度控制的潜在益处的证据有限。一个多中心随机对照试验(No:NCT00457431)对IHCA复苏患者进行体温控制、低温和常温的比较,其结果尚未归
    3 低温治疗在临床上可能有效的治疗窗口
    4 温度控制的最佳持续时间
    5 温度控制的临床效果是否取决于根据脑损伤的严重程度所提供适当的变量(目标温度和持续时间)
    6 是否存在能从低温控制中获益的心脏骤停后特定人群
    7 心脏骤停后患者的最佳镇静策略
    下载: 导出CSV
  • [1]

    冯梦云, 尚桂莲. 心脏骤停后低温治疗时间窗的研究进展[J]. 临床急诊杂志, 2021, 22(3): 216-221. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZLC202103015.htm

    [2]

    Bernard SA, Gray TW, Buist MD, et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia[J]. N Engl J Med, 2002, 346(8): 557-563. doi: 10.1056/NEJMoa003289

    [3]

    Nolan JP, Morley PT, Hoek TL, et al. Therapeutic hypothermia after cardiac arrest. An advisory statement by the Advancement Life support Task Force of the International Liaison committee on Resuscitation[J]. Resuscitation, 2003, 57(3): 231-235. doi: 10.1016/S0300-9572(03)00184-9

    [4]

    Geocadin RG, Wijdicks E, Armstrong MJ, et al. Practice guideline summary: Reducing brain injury following cardiopulmonary resuscitation: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology[J]. Neurology, 2017, 88(22): 2141-2149. doi: 10.1212/WNL.0000000000003966

    [5]

    Group HS. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest[J]. New Engl J Med, 2002, 346(8): 549-556. doi: 10.1056/NEJMoa012689

    [6]

    Nielsen N, Wetterslev J, Cronberg T, et al. Targeted temperature management at 33℃ versus 36℃ after cardiac arrest[J]. The New England journal of medicine, 2013, 369(23): 2197-2206. doi: 10.1056/NEJMoa1310519

    [7]

    Nolan JP, Soar J, Cariou A, et al. European Resuscitation Council and European Society of Intensive Care Medicine 2015 guidelines for post-resuscitation care[J]. Intensive Care Med, 2015, 41(12): 2039-2056. doi: 10.1007/s00134-015-4051-3

    [8]

    Lascarrou JB, Merdji H, Le Gouge A, et al. Targeted Temperature Management for Cardiac Arrest with Nonshockable Rhythm[J]. N Engl J Med, 2019, 381(24): 2327-2337. doi: 10.1056/NEJMoa1906661

    [9]

    Soar J, Berg KM, Andersen LW, et al. Adult Advanced Life Support: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations[J]. Resuscitation, 2020, 156: A80-A119. doi: 10.1016/j.resuscitation.2020.09.012

    [10]

    Dankiewicz J, Cronberg T, Lilja G, et al. Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest[J]. N Engl J Med, 2021, 384(24): 2283-2294. doi: 10.1056/NEJMoa2100591

    [11]

    Le May M, Osborne C, Russo J, et al. Effect of Moderate vs Mild Therapeutic Hypothermia on Mortality and Neurologic Outcomes in Comatose Survivors of Out-of-Hospital Cardiac Arrest: The CAPITAL CHILL Randomized Clinical Trial[J]. JAMA, 2021, 326(15): 1494-1503. doi: 10.1001/jama.2021.15703

    [12]

    Sandroni C, Nolan JP, Andersen LW, et al. ERC-ESICM guidelines on temperature control after cardiac arrest in adults[J]. Intensive Care Med, 2022, 48(3): 261-269. doi: 10.1007/s00134-022-06620-5

    [13]

    Granfeldt A, Holmberg MJ, Nolan JP, et al. Targeted temperature management in adult cardiac arrest: Systematic review and meta-analysis[J]. Resuscitation, 2021, 167: 160-172. doi: 10.1016/j.resuscitation.2021.08.040

    [14]

    Alonso-Coello P, Oxman AD, Moberg J, et al. GRADE Evidence to Decision(EtD)frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines[J]. Gac Sanit, 2018, 32(2): 167.

    [15]

    Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations[J]. BMJ, 2008, 336(7650): 924-926. doi: 10.1136/bmj.39489.470347.AD

    [16]

    Coppler PJ, Marill KA, Okonkwo DO, et al. Concordance of Brain and Core Temperature in Comatose Patients After Cardiac Arrest[J]. Ther Hypothermia Temp Manag, 2016, 6(4): 194-197. doi: 10.1089/ther.2016.0010

    [17]

    Fernando SM, Di Santo P, Sadeghirad B, et al. Targeted temperature management following out-of-hospital cardiac arrest: a systematic review and network meta-analysis of temperature targets[J]. Intensive Care Med, 2021, 47(10): 1078-1088. doi: 10.1007/s00134-021-06505-z

    [18]

    Obermeyer Z, Samra JK, Mullainathan S. Individual differences in normal body temperature: longitudinal big data analysis of patient records[J]. BMJ, 2017, 359: j5468.

    [19]

    Kirkegaard H, Søreide E, de Haas I, et al. Targeted Temperature Management for 48 vs 24 Hours and Neurologic Outcome After Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial[J]. JAMA, 2017, 318(4): 341-350. doi: 10.1001/jama.2017.8978

    [20]

    Bro-Jeppesen J, Hassager C, Wanscher M, et al. Post-hypothermia fever is associated with increased mortality after out-of-hospital cardiac arrest[J]. Resuscitation, 2013, 84(12): 1734-1740. doi: 10.1016/j.resuscitation.2013.07.023

    [21]

    Zeiner A, Holzer M, Sterz F, et al. Hyperthermia after cardiac arrest is associated with an unfavorable neurologic outcome[J]. Arch Intern Med, 2001, 161(16): 2007-2012. doi: 10.1001/archinte.161.16.2007

    [22]

    Pittl U, Schratter A, Desch S, et al. Invasive versus non-invasive cooling after in-and out-of-hospital cardiac arrest: a randomized trial[J]. Clin Res Cardiol, 2013, 102(8): 607-614. doi: 10.1007/s00392-013-0572-3

    [23]

    Deye N, Cariou A, Girardie P, et al. Endovascular Versus External Targeted Temperature Management for Patients With Out-of-Hospital Cardiac Arrest: A Randomized, Controlled Study[J]. Circulation, 2015, 132(3): 182-193. doi: 10.1161/CIRCULATIONAHA.114.012805

    [24]

    Look X, Li H, Ng M, et al. Randomized controlled trial of internal and external targeted temperature management methods in post-cardiac arrest patients[J]. Am J Emerg Med, 2018, 36(1): 66-72. doi: 10.1016/j.ajem.2017.07.017

    [25]

    Polderman KH. Application of therapeutic hypothermia in the ICU: opportunities and pitfalls of a promising treatment modality. Part 1: Indications and evidence[J]. Intensive Care Med, 2004, 30(4): 556-575. doi: 10.1007/s00134-003-2152-x

    [26]

    Marion DW, Leonov Y, Ginsberg M, et al. Resuscitative hypothermia[J]. Crit Care Med, 1996, 24(2 Suppl): S81-89.

    [27]

    Olai H, Thornéus G, Watson H, et al. Meta-analysis of targeted temperature management in animal models of cardiac arrest[J]. Intensive Care Med Exp, 2020, 8(1): 3. doi: 10.1186/s40635-019-0291-9

    [28]

    Bernard S A, Smith K, Cameron P, et al. Induction of therapeutic hypothermia by paramedics after resuscitation from out-of-hospital ventricular fibrillation cardiac arrest: a randomized controlled trial[J]. Circulation, 2010, 122(7): 737-742. doi: 10.1161/CIRCULATIONAHA.109.906859

    [29]

    Kim F, Nichol G, Maynard C, et al. Effect of prehospital induction of mild hypothermia on survival and neurological status among adults with cardiac arrest: a randomized clinical trial[J]. JAMA, 2014, 311(1): 45-52. doi: 10.1001/jama.2013.282173

    [30]

    Castrén M, Nordberg P, Svensson L, et al. Intra-arrest transnasal evaporative cooling: a randomized, prehospital, multicenter study(PRINCE: Pre-ROSC IntraNasal Cooling Effectiveness)[J]. Circulation, 2010, 122(7): 729-736. doi: 10.1161/CIRCULATIONAHA.109.931691

    [31]

    Nordberg P, Taccone FS, Truhlar A, et al. Effect of Trans-Nasal Evaporative Intra-arrest Cooling on Functional Neurologic Outcome in Out-of-Hospital Cardiac Arrest: The PRINCESS Randomized Clinical Trial[J]. JAMA, 2019, 321(17): 1677-1685. doi: 10.1001/jama.2019.4149

    [32]

    Ma Q, Feng L, Wang T, et al. 2020 expert consensus statement on neuro-protection after cardiac arrest in China[J]. Ann Transl Med, 2021, 9(2): 175. doi: 10.21037/atm-20-7853

    [33]

    马青变, 王军红, 陈玉娇, 等. 成人心脏骤停后综合征诊断和治疗中国急诊专家共识[J]. 中国急救医学, 2021, 41(7): 578-587. doi: 10.3969/j.issn.1002-1949.2021.07.009

    [34]

    Lascarrou JB, Guichard E, Reignier J, et al. Impact of rewarming rate on interleukin-6 levels in patients with shockable cardiac arrest receiving targeted temperature management at 33℃: the ISOCRATE pilot randomized controlled trial[J]. Crit Care, 2021, 25(1): 434. doi: 10.1186/s13054-021-03842-9

    [35]

    吴文娟, 马耀, 任节. 脑电双频指数对心肺复苏术后患者接受不同亚低温治疗策略的疗效评估[J]. 临床急诊杂志, 2020, 21(3): 198-203. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZLC202003006.htm

  • 加载中
计量
  • 文章访问数:  1423
  • PDF下载数:  608
  • 施引文献:  0
出版历程
收稿日期:  2022-04-25
刊出日期:  2022-06-10

目录